Dear Colleagues,
My colleague Valeria D'Eramo, would like to acquire skills to develop
Systematic Reviews. Can you recommend some freely available online
courses for her to start with? She would need to whole bit, from
generating a protocol, doing the systematic search, critical appraisal
and data extraction and analysis. Although she would like to begin with
SR of RCTs, training material for screening studies and other types of
studies is very welcome.
Thanks,
Anne Rutjes
A.W.S. Rutjes, PhD
Department of Clinical Epidemiology & Biostatistics
Academic Medical Center, University of Amsterdam
Locationcode J2-205
PO Box 22700, 1100 DE Amsterdam
The Netherlands
Phone: +31-(0)20-5666877
Fax: +31-(0)20-6912683
E-mail: [log in to unmask]
Department of Clinical Pharmacology and Epidemiology
Consorzio Mario Negri Sud,
Via Nazionale 8,
66030 Santa Maria Imbaro, Chieti, Italy
Phone: +39 087 257 03 22
Fax: +39 087 257 02 06
----- Original Message -----
From: Eddy Lang <[log in to unmask]>
Date: Friday, November 3, 2006 6:43 am
Subject: Re: Research practice gap
>
> Good point Rakesh but I think it's getting away a bit from Jon's
> question which is very much on my mind these days as I'll explain
> below.
> Speaking from the emergency medicine perspective I can tell you
> that there are probably a multitude of flagrant gaps between what
> is known from validated research and what is done in practice.
> Some of these are probably justified for reasons that have been
> suggested in this discussion but others seem to have their own
> signature set of "obstacles to uptake" covering the spectrum from
> the research is: unknown, not understood or accepted or
> logistically difficult to implement or there's just too much
> inertia associated with the status quo.
>
> This is pretty anecdotal though and in our literature there are
> relatively few studies that have documented the research to
> practice gap in everyday practice. Exceptions are related to the
> limited use of validated decision rules, interventions for Acute
> Coronary Syndromes and the inappropriate use of antibiotics as
> examples of the best studied culprits.
>
>
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16639050&query_hl=1&itool=pubmed_docsum
>
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16166599&query_hl=3&itool=pubmed_docsum
>
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16514122&query_hl=5&itool=pubmed_docsum
>
> This is all about that much discussed area that many have described
> with the term "Knowledge Translation".
>
> A few weeks ago Dr. Mayer brought to your attention an effort
> underway in emergency medicine to tackle this issue with a
> consensus conference on KT (research and implementation agenda
> building) sponsored by one of our journals.
>
> I'll use this opportunity to invite anyone on this list who has an
> interest in learning more and is potentially interested in getting
> involved in the process to contact me.
>
> Thanks,
>
> Eddy Lang
> Coordinator 2007 Academic Emergency Medicine
> Consensus Conference on Knowledge Translation
> http://saem.org/newsltr/2006/july-aug/aemcc.pdf
>
http://www.saem.org/saemdnn/Meetings/AnnualMeeting/AEMConsensusConference2007/tabid/362/Default.aspx
>
> ----- Original Message -----
> From: Rakesh Biswas
> To: [log in to unmask]
> Sent: Thursday, November 02, 2006 11:36 PM
> Subject: Re: Research practice gap
>
>
> I would think its good that they aren't used when they do not
> show significant clinical benefit.
> The problem is inspite of the evidence in systematic reviews
> (perhaps not single trials) to the contrary certain drugs like
> trimetazidine (to optimize coronary angina), neuroprotectives like
> nootropil, hepatoprotectives (and supposed Nh3 reducers), even
> calcitriol for reducing AED induced hypocalcemia, IV Ig in Toxic
> epidermal necrolysis are often exploited by drug companies to sell
> their wares to gullible physicians (unknowingly exploiting their
> patients).
> One of the best contributions of EBM till date has been the
> scientific approach to therapeutics that gets rid of unnecessary
> ineffective therapies but there always exist certain therapies that
> evidence doesn't encourage swallowing but drug companies do (to
> make good the losses incurred on the research that went into the
> drug ).
> Rakesh
>
>
> On 11/3/06, Lesley Kay <[log in to unmask]> wrote:
> the trials of viscosupplementation for osteoarthritis show
> statistical but not significant clinical benefit and so are not
> generally used in
> practice
> Lesley
>
> On 2 Nov 2006, at 16:20, Jon Brassey wrote:
>
> > Hi!
> >
> > Does anyone have any good examples of where clinical
> trials/systematic > reviews have published results which simply
> don't translate into
> > everyday practice?
> >
> > Best wishes
> >
> > jon
> >
> > Jon Brassey
> > TRIP Database
> > www.tripdatabase.com
> >
> >
> > -----------------------------------------
> > Email sent from www.ntlworld.com
> > Virus-checked using McAfee(R) Software
> > Visit www.ntlworld.com/security for more information
> >
> >
> Lesley Kay
> Consultant Rheumatologist and Honorary Senior Lecturer
> Freeman Hospital
> Newcastle upon Tyne
> NE7 7DN
> 0191 233 6161 x 37867 (Carole)
>
>
>
|